UroGen Pharma Balance Sheet (2016-2026) | URGN

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & Equivalents (Quarter)
55.34M44.36M105.38M46.45M28.69M55.41M36.54M20.13M119.31M95.00M131.44M219.97M124.92M171.99M104.03M92.90M90.04M110.75M109.97M79.13M
Short-term Investments (Quarter)
50.87M44.78M31.07M31.05M67.22M44.56M28.51M27.17M28.11M41.97M32.61M21.11M124.66M64.70M91.86M64.05M36.99M9.71M30.31M28.84M
Cash & Current Investments (Quarter)
106.21M89.14M136.44M77.50M95.91M99.96M65.05M47.30M147.42M136.97M164.04M241.08M249.57M236.69M195.89M156.95M127.03M120.46M140.27M107.97M
Receivables - Net (Quarter)
7.78M11.72M9.50M11.60M9.43M12.70M12.49M15.51M12.85M15.44M14.16M17.41M22.80M20.30M19.64M19.65M19.70M33.08M55.41M88.76M
Receivables (Quarter)
7.78M11.72M9.50M11.60M9.43M12.70M12.49M15.51M12.85M15.44M14.16M17.41M22.80M20.30M19.64M19.65M19.70M33.08M55.41M88.76M
Raw Materials (Quarter)
Finished Goods (Quarter)
Inventory (Quarter)
3.81M4.83M4.76M5.05M4.86M4.33M5.47M4.99M5.00M5.67M7.24M7.44M7.59M9.23M7.59M7.13M8.34M16.46M20.92M24.59M
Prepaid Assets (Quarter)
6.11M7.48M9.28M10.43M10.58M11.10M12.15M12.72M16.04M10.28M10.49M12.21M14.05M8.85M12.98M12.05M12.12M14.67M19.53M12.78M
Current Assets (Quarter)
125.14M114.39M160.52M139.62M121.59M128.91M95.97M81.33M182.12M169.19M196.76M278.97M295.10M276.13M237.18M196.87M168.55M186.02M237.46M235.43M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
1.98M1.97M1.78M1.60M1.52M1.30M1.10M0.91M0.82M0.69M0.57M0.58M0.61M0.66M0.63M0.69M0.69M0.64M0.62M0.60M
Long-Term Investments (Quarter)
4.07M0.68M0.67M0.67M0.22M0.22M10.16M7.97M6.51M4.50M0.48M0.20M4.64M5.02M4.51M4.63M0.38M0.18M0.18M0.18M
Long-Term Deferred Tax (Quarter)
103.57M122.94M153.35M
Other Non-Current Assets (Quarter)
1.77M1.31M1.57M1.90M2.47M2.74M3.16M2.82M2.05M2.04M1.10M0.67M0.37M0.59M0.37M0.80M6.76M5.16M7.49M8.76M
Non-Current Assets (Quarter)
9.46M5.36M5.19M6.52M6.88M6.71M16.98M14.03M11.51M9.12M3.81M2.88M6.85M9.58M10.44M11.85M16.50M14.43M16.23M17.16M
Assets (Quarter)
134.60M119.75M165.72M146.14M128.47M135.62M112.95M95.36M193.63M178.31M200.57M281.85M301.94M285.71M247.62M208.72M185.05M200.46M253.69M252.59M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
11.06M12.10M9.94M8.65M9.36M12.38M17.13M16.40M14.08M16.54M18.16M23.75M19.68M27.43M30.32M30.96M26.17M27.72M35.35M39.95M
Payables (Quarter)
11.06M12.10M9.94M8.65M9.36M12.38M17.13M16.40M14.08M16.54M18.16M23.75M19.68M27.43M30.32M30.96M26.17M27.72M35.35M39.95M
Accumulated Expenses (Quarter)
6.48M6.95M5.15M6.43M6.62M8.26M4.92M6.72M8.15M10.81M4.99M6.85M9.03M10.57M6.97M11.65M11.11M13.52M9.84M12.25M
Other Accumulated Expenses (Quarter)
2.27M3.33M4.01M2.96M3.02M3.28M3.19M3.64M3.55M3.86M3.20M3.62M4.07M7.95M4.71M4.94M4.96M5.18M5.45M7.62M
Current Deferred Revenue (Quarter)
Current Leases (Quarter)
1.27M1.41M
Total Current Liabilities (Quarter)
61.91M
Non-Current Liabilities
Non-Current Debt (Quarter)
188.73M
Operating Leases (Quarter)
3.04M
Capital Leases (Quarter)
3.48M2.94M
Other Non-Current Liabilities (Quarter)
3.90M
Total Non-Current Liabilities (Quarter)
381.08M
Total Liabilities (Quarter)
384.99M
Shareholder's Equity
Total Debt (Quarter)
188.73M
Common Equity (Quarter)
-132.40M
Liabilities and Shareholders Equity (Quarter)
252.59M
Retained Earnings (Quarter)
-997.64M
Preferred Shares (Quarter)
Treasury Shares (Quarter)
0.75M0.69M1.10M1.51M1.93M